CAS: 366017-09-6 - Mubritinib
Formula:C25H23F3N4O2
InChI:InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+
InChI key:InChIKey=ZTFBIUXIQYRUNT-MDWZMJQESA-N
SMILES:FC(F)(F)C1=CC=C(C=CC2=NC(=CO2)COC3=CC=C(C=C3)CCCCN4N=NC=C4)C=C1
- Sinonimi:
- 1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
- 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole
- 1H-1,2,3-Triazole, 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-
- Tak 165
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Mubritinib REF: AN-AG0078T8CAS: 366017-09-6 | ≥99% | 133,00 €~489,00 € | Gio 16 Mag 24 | |
Mubritinib REF: 7W-GP2351CAS: 366017-09-6 | ≥ 95.0% | Prezzo su richiesta | Ven 17 Mag 24 | |
Mubritinib REF: 3B-M3058CAS: 366017-09-6 | >98.0%(HPLC) | 211,00 €~687,00 € | Mar 21 Mag 24 | |
Mubritinib REF: TM-T6124CAS: 366017-09-6 | 99.87% | 38,00 €~326,00 € | Gio 23 Mag 24 | |
Mubritinib REF: 3D-FM32802CAS: 366017-09-6 | Min. 95% | Prezzo su richiesta | Gio 27 Giu 24 |
Mubritinib
- Antitumorale
- Attivatori e inibitori enzimatici
- Principi attivi farmaceutici (API) per la ricerca
- Enzimi
- Vedere altre categorie
- EGFR
- Neuroscienza
- Adattatori Tirosin-chinasi
- Ricerca sul cancro
- Composti correlati al principio attivo farmaceutico (API)
- Prodotti biochimici e reagenti
- Biologia cellulare e molecolare
Ref: AN-AG0078T8
10mg | 133,00 € | |
50mg | 489,00 € |
Mubritinib
Ref: 7W-GP2351
Dimensione non definita | Prezzo su richiesta |
Mubritinib
Ref: 3B-M3058
25mg | 211,00 € | |
100mg | 687,00 € |
Mubritinib
Ref: TM-T6124
5mg | 38,00 € | |
10mg | 56,00 € | |
25mg | 102,00 € | |
50mg | 171,00 € | |
100mg | 326,00 € | |
1ml*10 (DMSO) | 54,00 € |
Mubritinib
Ref: 3D-FM32802
10mg | Prezzo su richiesta | |
50mg | Prezzo su richiesta |